Welcome to our dedicated page for Datametrex Ai Li news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex Ai Li stock.
The Datametrex AI Limited (DTMXF) news page on Stock Titan aggregates company announcements and updates related to its activities in Technology Solutions, Artificial Intelligence, fintech payments, and healthcare. Datametrex regularly issues news releases covering its subsidiaries, new contracts, acquisitions, and operational developments.
Investors and followers can review updates on Datametrex Korea, the company’s wholly owned subsidiary that secures IT infrastructure and technology solutions purchase orders from large global enterprises. These items often highlight new purchase orders, revenue expectations tied to those orders, and commentary on the company’s "land and expand" approach with global partners.
The news feed also features developments from Paymetrex Payment Solutions Inc., another wholly owned subsidiary focused on payment technologies. Recent releases describe a Technology Licensing Agreement with AnywhereCommerce Inc., plans to market payment solutions under the YuzuPay brand, and the acquisition of the Yuzu Payment Solution from Firstpayment Inc., including related patents and intellectual property.
Healthcare-related news appears through Imagine Health Medical Clinics Ltd., Datametrex’s wholly owned healthcare subsidiary. Announcements include clinic relocations in Calgary and Edmonton, the opening of new facilities, the launch of walk-in services for urgent, non-emergency care, and the addition of new physicians to expand capacity for family medicine and specialized medical services.
By following this page, readers can access a chronological record of Datametrex’s disclosed activities across technology, payments, and healthcare. The coverage includes corporate strategy updates, subsidiary milestones, and participation in capital markets events, helping users understand how the company presents its progress and business initiatives over time.
Datametrex (OTC:DTMXF) subsidiary Paymetrex entered a Technology Licensing Agreement dated December 17, 2025 with AnywhereCommerce to access its payment products and services.
Paymetrex will combine AnywhereCommerce technology with its proprietary IP, market payment solutions under the YuzuPay brand via direct sales, ISVs and ISOs, and appoint resellers across luxury merchant categories. Paymetrex holds a 10‑patent granted portfolio and plans to file at least one provisional patent for quantum‑enhanced payment security.
The release cites AnywhereCommerce's deployment of 20 million devices across 15 countries and a Grand View Research crypto payments market projection from USD 556.9M (2024) to USD 2.4B (2033) at a 17.8% CAGR.
Datametrex (OTC:DTMXF) completed the acquisition of the Yuzu payment processing solution from Firstpayment via subsidiary Paymetrex on December 19, 2025. The purchase price was $5.5 million, satisfied by issuance of 55,000,000 common shares at a deemed price of $0.10 per share, subject to a four-month-and-one-day hold period.
The company did not assume Firstpayment debt. Proceeds from a prior private placement were released from escrow to fund integration of Yuzu and merchant commercialization efforts. Michael Kron was appointed to the board and now holds approximately 12.15% of outstanding common shares.
Datametrex (OTC:DTMXF) signed a definitive asset purchase agreement dated December 9, 2025 to acquire the Yuzu payment processing solution, including related patents and intellectual property, from Firstpayment for a purchase price of $5.5 million.
The purchase price will be satisfied by issuing 55,000,000 common shares at a deemed price of $0.10 per share to Firstpayment. Completion is expected on or about December 17, 2025, subject to customary closing conditions and TSXV approval.
Upon closing, proceeds from a previously announced private placement will be released from escrow to integrate Yuzu into Datametrex's technology division and pursue merchant revenue opportunities; Michael Kron is expected to join the board and serve as COO of Paymetrex.
Datametrex (OTC:DTMXF) announced on December 1, 2025 that its wholly owned subsidiary Imagine Health has launched walk-in services at Calgary and Edmonton clinics, and is accepting new family patients.
Both clinics operate Monday to Friday, 8:30 AM–4:30 PM, and will treat same-day, non-emergency needs including respiratory infections, minor injuries, urgent prescriptions, and chronic condition flare-ups. Locations, phone numbers, and clinic hours are provided for patient access.
The company said the expansion advances its goal of improving timely, patient-focused care across Western Canada and signals continued exploration of broader clinic network growth.
Datametrex (OTC:DTMXF) announced on November 27, 2025 that its subsidiary Datametrex Korea secured purchase orders totaling approximately CAD $650,000. The P.O.s represent roughly CAD $650,000 in new revenue with an approximate 20% gross profit margin. The company described the orders as part of its land and expand strategy and said they reinforce its role as an IT infrastructure solutions provider to major global partners.
The announcement highlights contribution from Korean operations and management commentary emphasizing continued partnership-driven growth and operational execution.
Datametrex AI (OTC:DTMXF) announced that its wholly owned subsidiary Imagine Health added four new physicians and is accepting new patients in Calgary and Edmonton as of November 24, 2025.
Calgary clinics added Dr. Younis, Dr. Rezaeisarlak, and Dr. Fiselier to expand insured primary-care services under Alberta's provincial system. Edmonton clinic added Dr. Abdulkadir to increase capacity and access. The release lists clinic addresses, phone numbers, fax numbers, and Monday–Friday hours for booking appointments.
DataMetrex (OTC:DTMXF) announced that subsidiary Imagine Health Medical Clinics has reopened its Edmonton South clinic at 2551 Hewes Way NW, Suite 104, Edmonton, AB T6L 6W6. The new facility is open and accepting new patients seeking a family physician.
Clinic contact: (780) 468-5999, fax 1 (855) 751-0323. Hours: Monday–Friday, 8:30 AM–4:30 PM. Management said the relocation provides a modern, accessible space intended to support patient-focused care across Alberta.
Datametrex AI (OTC:DTMXF) announced that its wholly owned subsidiary Imagine Health Medical Clinics has relocated its Calgary clinic to Capitol Hill and is now fully operational.
New address: 2004 14 Street NW, Suite 207, Calgary, Alberta T2M 3N3. Clinic hours are Monday–Friday, 8:30 AM–4:30 PM. Contact: (403) 775-9669 or fax 1 (866) 483-1816. The clinic is accepting new patients and bookings by phone or fax.
Datametrex (OTC:DTMXF) closed two financings on November 14, 2025, raising aggregate gross proceeds of $5,133,500 through a common share private placement (47,918,750 shares at $0.08; $3,833,500) and a subscription receipt financing (16,250,000 receipts at $0.08; $1,300,000).
The subscription proceeds are escrowed pending satisfaction of escrow release conditions tied to the proposed acquisition of the Yuzu Payment Solution, with an escrow release deadline of December 31, 2025. Proceeds will fund Yuzu integration, merchant opportunities, a new clinic location, and working capital. Finders fees total $130,000 cash plus 1,625,000 finders warrants for the subscription financing and cash and equity finders fees for the common placement. Insider Andrew Ryu acquired 16,250,000 shares (~16.65%).
Datametrex AI (TSXV:DM / FSE:D4G / OTC:DTMXF) announced it intends to close two financings on November 14, 2025: a non-brokered private placement and a subscription receipt financing.
The company plans to issue up to 50,000,000 common shares at $0.08 for gross proceeds up to $4,000,000, and up to 16,250,000 subscription receipts at $0.08 for gross proceeds up to $1,300,000, totaling up to $5,300,000 in gross proceeds.
Net proceeds are designated for business expansion, a new location, integration of the Yuzu Payment Solution into Datametrex's technology division, and general working capital. The company may pay finder's fees up to 5% cash, 5% shares and 10% warrants or alternatively up to 10% cash and 10% warrants. All securities will be subject to a statutory hold period of four months plus one day.